Opportunity Information: Apply for 72065621USAIDSBCMALARIA
The USAID Social and Behavior Change (SBC) Malaria Program in Mozambique is a planned health initiative from USAID/Mozambique (Integrated Health Office) focused on improving malaria prevention and treatment behaviors in selected target areas of the country. The opportunity is framed as a request for feedback on a draft Program Description, meaning USAID was actively gathering input from organizations and technical experts to shape the final design of the program before launching a full solicitation. The intent is to ensure the future program is grounded in evidence-based and theory-driven SBC approaches that can measurably influence how communities prevent malaria and seek timely diagnosis and treatment.
At its core, the program is aimed at strengthening both the implementation and the monitoring of proven malaria SBC interventions, while also improving how malaria SBC is designed, carried out, and tracked by Mozambique's Ministry of Health and its implementation partners. In practical terms, this signals a dual emphasis: first, delivering high-quality SBC activities that directly affect community knowledge, attitudes, and practices related to malaria, and second, building institutional capacity so government and partner systems can plan, manage, and measure SBC work more effectively over time. The language around "increase implementation and monitoring" and "improve design, implementation, and monitoring" suggests USAID wants not only outreach and communication activities, but also stronger SBC strategy development, partner coordination, and performance management tied to clear indicators.
The funding mechanism listed is a Cooperative Agreement, which typically means USAID expects substantial involvement in the program's direction, collaboration on key decisions, and ongoing technical engagement rather than a hands-off grant. The opportunity category is listed as an earmark, and the activity area is health, under CFDA 98.001. Eligibility is described as unrestricted, indicating that a wide range of applicants could potentially apply, including nonprofits, for-profits, universities, and other qualified entities, assuming they meet standard USAID requirements. The posted award ceiling is $6,000,000, which provides a sense of the program's maximum anticipated size, though the posting does not specify a final number of awards or an exact implementation period in the excerpt provided.
Because this announcement was specifically aimed at collecting "industry comment" on a draft Program Description, organizations were being asked to respond to USAID's technical questions and to demonstrate relevant capabilities that could inform the final scope of work. USAID notes that any information submitted could be used in developing the anticipated Program Description, a common approach in pre-solicitation market research to refine objectives, confirm feasibility, identify innovation opportunities, and better understand what potential partners can realistically deliver in Mozambique's operating context. The original closing date for feedback was June 10, 2021, and the opportunity was created on May 20, 2021, placing it clearly in a planning and consultation phase rather than a finalized competitive application stage based on the text provided.
Overall, the opportunity reflects USAID's intent to invest in stronger, more measurable social and behavior change programming as a key part of malaria control in Mozambique, with particular attention to evidence-based interventions, behavior-focused outcomes, and improved national and partner capacity to design, implement, and monitor SBC activities at scale.Apply for 72065621USAIDSBCMALARIA
- The Mozambique USAID-Maputo in the health sector is offering a public funding opportunity titled "USAID Social and Behavior Change (SBC) MALARIA Program in Mozambique" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 98.001.
- This funding opportunity was created on 2021-05-20.
- Applicants must submit their applications by 2021-06-10. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $6,000,000.00 in funding.
- Eligible applicants include: Unrestricted.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Health
Next opportunity: Enhancing the Coastal and Ocean Capabilities in the Pacific
Previous opportunity: USAID/Bangladesh Request for Information on USAID’s Community Nutrition and Health Activity
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for 72065621USAIDSBCMALARIA
Applicants also applied for:
Applicants who have applied for this opportunity (72065621USAIDSBCMALARIA) also looked into and applied for these:
| Funding Opportunity |
|---|
| Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Research Training Award (NCD-LIFESPAN) (D43 Clinical Trial Optional) Apply for PAR 21 230 Funding Number: PAR 21 230 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Adapting Immunotherapy and Gene Editing Based Strategies for Targeting HIV Reservoirs in the CNS: Potential Benefits and Risks (R01 Clinical Trial Optional) Apply for RFA MH 21 225 Funding Number: RFA MH 21 225 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Adapting Immunotherapy and Gene Editing Based Strategies for Targeting HIV Reservoirs in the CNS: Potential Benefits and Risks (R21 Clinical Trial Optional) Apply for RFA MH 21 226 Funding Number: RFA MH 21 226 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01 Independent Clinical Trial Required) Apply for RFA HL 22 010 Funding Number: RFA HL 22 010 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01 Independent Clinical Trial Not Allowed) Apply for RFA HL 22 011 Funding Number: RFA HL 22 011 Agency: National Institutes of Health Category: Health Funding Amount: $150,000 |
| NIA Postdoctoral Fellowship Award to Promote Diversity in Translational Research for AD/ADRD (F32 Clinical Trial Not Allowed) Apply for PAR 21 217 Funding Number: PAR 21 217 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIA Advanced Postdoctoral Career Transition Awards to Promote Diversity in Translational Research for AD/ADRD (K99/R00 Clinical Trial Not Allowed) Apply for PAR 21 220 Funding Number: PAR 21 220 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIA Predoctoral Fellowship Award to Promote Diversity in Translational Research for AD/ADRD (F31) Apply for PAR 21 218 Funding Number: PAR 21 218 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Diagnostic-Telemedicine Resource (U24 Clinical Trial Not Allowed) Apply for RFA AA 21 012 Funding Number: RFA AA 21 012 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Developmental Project (UH2 Clinical Trial Optional) Apply for RFA AA 21 014 Funding Number: RFA AA 21 014 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Data Coordination Resource (U24 Clinical Trial Not Allowed) Apply for RFA AA 21 013 Funding Number: RFA AA 21 013 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Administrative Resource (U24) (Clinical Trial Not Allowed) Apply for RFA AA 21 011 Funding Number: RFA AA 21 011 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Research Project (U01 Clinical Trial optional) Apply for RFA AA 21 010 Funding Number: RFA AA 21 010 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Non-Human Primate Developmental Genotype-Tissue Expression (NHP dGTEx) Project (U24 Clinical Trials Not Allowed) Apply for RFA HG 21 026 Funding Number: RFA HG 21 026 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIH Directors Transformative Research Awards (R01 Clinical Trial Optional) Apply for RFA RM 21 017 Funding Number: RFA RM 21 017 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Shared Personal Protective Equipment (PPE) Resources (S10 Clinical Trial Not Allowed) Apply for PAR 21 257 Funding Number: PAR 21 257 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Integration, Dissemination, and Evaluation (BRIDGE) Center for the NIH Bridge to Artificial Intelligence (Bridge2AI) Program (U54 Clinical Trial Not Allowed) Apply for RFA RM 21 023 Funding Number: RFA RM 21 023 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Large Research Projects for Prevention of Healthcare-Associated Infections (R01) Apply for PA 21 265 Funding Number: PA 21 265 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $500,000 |
| High Resolution Mapping of Biomolecules in Brain Cells in Aging and Alzheimers Disease (R01 Clinical Trial Not Allowed) Apply for RFA AG 22 019 Funding Number: RFA AG 22 019 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Promoting Bunyavirales Basic Science Research (R01 Clinical Trial Not Allowed) Apply for RFA AI 21 046 Funding Number: RFA AI 21 046 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "72065621USAIDSBCMALARIA", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
